Ames R S, Tornetta M A, McMillan L J, Kaiser K F, Holmes S D, Appelbaum E, Cusimano D M, Theisen T W, Gross M S, Jones C S
Department of Molecular Immunology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
J Immunol. 1995 Jun 15;154(12):6355-64.
Conventional hybridomas and combinatorial Ab libraries were used to develop neutralizing murine mAbs to human IL-5. Mice were immunized with rIL-5. Spleens from two mice were used to generate hybridomas. Spleens from an additional three mice were used to construct a combinatorial library. In both instances, Abs were identified and selected by ELISA using 96-well plates coated with rIL-5. These Abs were tested for the ability to block binding of iodinated rIL-5 to the alpha-chain of the human IL-5 receptor (IL-5R alpha) and to inhibit proliferation of IL-5-dependent cells. By hybridoma technology, 16 mAbs were obtained, 11 of which blocked binding to IL-5R alpha, including three that inhibited proliferation. Quantitative binding assays and sequence analysis revealed that these latter three mAbs were closely related. Combinatorial cloning and selection by phage display was used to isolate 24 bacterial colonies secreting Fabs that bound to 125I-rIL-5 and to rIL-5-coated plates. Sequencing of 10 of the Fabs indicated that four unique Abs were obtained, comprising one predominant VH paired with one of two different VL. The sequence of the Fabs was distinct from the sequences of the neutralizing mAbs. In contrast to the mAbs, none of the Fabs blocked binding of 125I-IL-5 to IL-5R alpha or neutralized the biologic activity of IL-5. The inability to identify neutralizing Fabs was shown not to result from their monovalency, because a Fab derived from one of the neutralizing mAbs, by cloning and expression of its Fd and kappa light chains, retained neutralizing activity. By chain shuffling, pairing of the Fd fragment of the heavy chain of one of the neutralizing mAbs (2B6), with the light chain library derived from the IL-5-immunized mice, neutralizing Fabs were obtained. These Fabs contained light chain sequences closely related to the original light chain of 2B6. Hence, chain shuffling allowed detection of a light chain sequence that was not evident upon two-chain combinatorial selection. The results reveal differences in the Abs obtained from a combinatorial library vs hybridomas and demonstrate how these approaches can be used in concert to select mAbs with neutralizing activity.
使用传统杂交瘤和组合抗体文库来开发针对人白细胞介素-5(IL-5)的中和性鼠单克隆抗体(mAb)。用重组IL-5免疫小鼠。取两只小鼠的脾脏用于产生杂交瘤。另外三只小鼠的脾脏用于构建组合文库。在这两种情况下,均使用包被有重组IL-5的96孔板通过酶联免疫吸附测定(ELISA)来鉴定和筛选抗体。检测这些抗体阻断碘化重组IL-5与人IL-5受体α链(IL-5Rα)结合以及抑制IL-5依赖细胞增殖的能力。通过杂交瘤技术获得了16种单克隆抗体,其中11种可阻断与IL-5Rα的结合,包括3种能抑制细胞增殖的抗体。定量结合分析和序列分析表明,后三种单克隆抗体密切相关。通过噬菌体展示进行组合克隆和筛选,分离出24个分泌与125I-重组IL-5及包被有重组IL-5的平板结合的Fab片段的细菌菌落。对其中10个Fab片段进行测序表明获得了4种独特的抗体,包括一种主要的重链可变区(VH)与两种不同轻链可变区(VL)之一配对的抗体。Fab片段的序列与中和性单克隆抗体的序列不同。与单克隆抗体不同,这些Fab片段均未阻断125I-IL-5与IL-5Rα的结合或中和IL-5的生物学活性。无法鉴定出中和性Fab片段并非由于其单价性所致,因为通过克隆和表达其中一种中和性单克隆抗体的Fd片段和κ轻链所得到的Fab片段仍保留中和活性。通过链改组,将其中一种中和性单克隆抗体(2B6)重链的Fd片段与源自经IL-5免疫小鼠的轻链文库进行配对,获得了中和性Fab片段。这些Fab片段包含与2B6原始轻链密切相关的轻链序列。因此,链改组使得能够检测到在双链组合筛选时不明显的轻链序列。结果揭示了从组合文库与杂交瘤获得的抗体之间的差异,并证明了如何将这些方法协同使用来筛选具有中和活性的单克隆抗体。